It will therefore be imperative to investigate TSPO expression on human tissue acquired from diseased patients vs. matched controls, and to examine the changes at different time-points, as there may be more pronounced/different neuroinflammatory responses exhibited in chronic human neurodegenerative disease or psychiatric disorders. This evidence concerns the gene TSPO and psychiatric disorder.